Securities
Issues & Trends
From 7,200 to the 6,800 level… ‘Rollercoaster KOSPI’ closes down about 1%
The KOSPI index crossed the 7,200 mark early in the session on the 18th but ended the day down more than 1% after a roller-coaster ride that saw it fall as low as the 6,700 level during the session. W…
Issues & Trends
Voronoi, Inc. Receives IND Approval in Singapore for Lung Cancer Treatment ‘VRN11’… Expands Global Phase 1 Clinical Trials
Voronoi, Inc.(310210)announced on the 18th that it has received approval from Singapore’s Health Sciences Authority (HSA) for the global Phase 1b/2 clinical trial plan (IND) for “VRN11,” its next-gene…
Issues & Trends
AU BRANDZ Co., Ltd Officially Launches Japanese Joint Venture… Expands Presence in Shinjuku and Osaka
K-fashion company #AU BRANDZ Co., Ltd is set to expand its business in Japan by launching its Japanese joint venture (JV), “AU BRANDZ JAPAN.” The company’s strategy is to continue pursuing revenue gro…
Issues & Trends
Noul Co., Ltd. Obtains Class II Medical Device Approval in Canada… "Accelerating Entry into the North American Market"
Noul Co., Ltd.(376930), a company specializing in AI-based blood and cancer diagnostics, announced on the 18th that it has obtained a Class II medical device license from Health Canada for the “Malari…
Issues & Trends
LaonPeople Inc. to Resume Trading on the 20th Following a Stock Split… “Full-Scale Profitability Begins”
AI specialist LaonPeople Inc.(300120)has completed a stock consolidation and will resume trading on the 20th. The company plans to pursue growth centered on profitability, building on its return to pr…
Issues & Trends
KOSPI Fluctuates Around the 6,900 Mark Amid Institutional Selling… Semiconductor Stocks 'Stall'
The KOSPI, which had risen as much as 3% early in the session, has given up all its gains and continues to trade lower around the 6,900 level in the afternoon. While retail and foreign investors are n…
Issues & Trends
VIVOZON PHARMACEUTICAL Reports 2Q Sales of 2 Billion Won for ‘Anaprazu’… Up 229% from the Previous Quarter
VIVOZON PHARMACEUTICAL(082800)announced on the 18th that sales of its non-narcotic analgesic “Anaprazu” reached approximately 2 billion won in the second quarter of this year, marking a 229% increase …
Issues & Trends
PLANTYNET Co., Ltd. Reports First-Half Revenue of 20 Billion Won… “Expanding Global Digital Care Business”
IT solutions specialist PLANTYNET Co., Ltd.(075130)announced on the 18th that it recorded consolidated revenue of 20.02 billion won, operating profit of 560 million won, and net income of 490 million …
Issues & Trends
SAM CHUN DANG PHARM CO. LTD Reaches Global Settlement with Regeneron and Bayer in Ailera 2mg Patent Dispute
SAM CHUN DANG PHARM CO. LTD(000250)has settled the global patent dispute it had been engaged in with Regeneron and Bayer regarding the Eylea biosimilar “SCD411.”SAM CHUN DANG PHARM CO. LTD announced o…
Issues & Trends
MDS Tech Reports First-Ever First-Half Revenue of 100 Billion… “Profitability Exceeds Last Year’s Full-Year Results”
MDS Tech(086960)reported that, driven by revenue growth in artificial intelligence (AI) and embedded solutions as well as improved performance from its subsidiaries, the company surpassed 100 billion …